Innospec Inc. (NASDAQ:IOSP) VP Philip John Boon Sells 3,754 Shares

Innospec Inc. (NASDAQ:IOSP) VP Philip John Boon sold 3,754 shares of the business’s stock in a transaction on Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $387,788.20. Following the transaction, the vice president now owns 20,079 shares of the company’s stock, valued at $2,074,160.70. This trade represents a 15.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Innospec Trading Down 1.3 %

Shares of NASDAQ IOSP opened at $101.99 on Tuesday. The business has a 50-day moving average of $110.59 and a 200-day moving average of $112.38. The firm has a market capitalization of $2.55 billion, a price-to-earnings ratio of 71.82 and a beta of 1.09. Innospec Inc. has a 12 month low of $99.49 and a 12 month high of $133.71.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.05. The business had revenue of $466.80 million during the quarter, compared to analysts’ expectations of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%. On average, analysts predict that Innospec Inc. will post 6.18 earnings per share for the current year.

Analysts Set New Price Targets

Separately, StockNews.com cut Innospec from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 11th.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Covestor Ltd lifted its stake in Innospec by 13.9% during the fourth quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company’s stock worth $106,000 after purchasing an additional 118 shares during the last quarter. Summit Investment Advisors Inc. raised its holdings in shares of Innospec by 4.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 2,608 shares of the specialty chemicals company’s stock valued at $287,000 after buying an additional 118 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Innospec by 8.8% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,868 shares of the specialty chemicals company’s stock worth $206,000 after buying an additional 151 shares during the last quarter. HighTower Advisors LLC boosted its stake in Innospec by 5.2% in the third quarter. HighTower Advisors LLC now owns 3,103 shares of the specialty chemicals company’s stock worth $350,000 after buying an additional 154 shares in the last quarter. Finally, Raymond James Trust N.A. grew its position in Innospec by 7.9% during the third quarter. Raymond James Trust N.A. now owns 2,106 shares of the specialty chemicals company’s stock valued at $238,000 after acquiring an additional 155 shares during the last quarter. Institutional investors own 96.64% of the company’s stock.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.